| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |